

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 7.34485372 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 7.34485372 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.68839958 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.26623745 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.26623745 |
| 6 | fatty acid elongation (GO:0030497) | 4.86764329 |
| 7 | myelination (GO:0042552) | 4.81539461 |
| 8 | ensheathment of neurons (GO:0007272) | 4.79848069 |
| 9 | axon ensheathment (GO:0008366) | 4.79848069 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66851870 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62590782 |
| 12 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.43323257 |
| 13 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.40938720 |
| 14 | presynaptic membrane assembly (GO:0097105) | 4.37431404 |
| 15 | negative regulation of T cell mediated immunity (GO:0002710) | 4.34623318 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.31690162 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29276736 |
| 18 | L-amino acid import (GO:0043092) | 4.21692876 |
| 19 | presynaptic membrane organization (GO:0097090) | 4.13909003 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.12484412 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.07038639 |
| 22 | negative regulation of neurotransmitter transport (GO:0051589) | 4.01922915 |
| 23 | positive T cell selection (GO:0043368) | 4.00251696 |
| 24 | response to interleukin-15 (GO:0070672) | 3.94997666 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 3.93533344 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86410614 |
| 27 | T cell migration (GO:0072678) | 3.85663513 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.82306561 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.82241391 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.54995966 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.54149719 |
| 32 | T cell selection (GO:0045058) | 3.54073984 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.43937936 |
| 34 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.43859177 |
| 35 | oligodendrocyte differentiation (GO:0048709) | 3.43627298 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.43264097 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.43264097 |
| 38 | regulation of memory T cell differentiation (GO:0043380) | 3.42256440 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.41478527 |
| 40 | response to type I interferon (GO:0034340) | 3.41240202 |
| 41 | leukocyte aggregation (GO:0070486) | 3.39656713 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.38719121 |
| 43 | thymic T cell selection (GO:0045061) | 3.36913183 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36060629 |
| 45 | detection of other organism (GO:0098543) | 3.34554268 |
| 46 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.33744585 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.28861461 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.28050034 |
| 49 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.28050034 |
| 50 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.28050034 |
| 51 | modulation by symbiont of host immune response (GO:0052553) | 3.28050034 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 3.28050034 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 3.28050034 |
| 54 | asymmetric protein localization (GO:0008105) | 3.25988887 |
| 55 | virion attachment to host cell (GO:0019062) | 3.23236067 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 3.23236067 |
| 57 | cellular response to ethanol (GO:0071361) | 3.23185415 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23080665 |
| 59 | myelin maintenance (GO:0043217) | 3.22350745 |
| 60 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.21297457 |
| 61 | T-helper cell differentiation (GO:0042093) | 3.21297457 |
| 62 | cellular extravasation (GO:0045123) | 3.19049837 |
| 63 | neuron cell-cell adhesion (GO:0007158) | 3.18839812 |
| 64 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18509316 |
| 65 | positive regulation of humoral immune response (GO:0002922) | 3.17370646 |
| 66 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.17271146 |
| 67 | detection of bacterium (GO:0016045) | 3.16884364 |
| 68 | interferon-gamma production (GO:0032609) | 3.15895429 |
| 69 | cerebellar granule cell differentiation (GO:0021707) | 3.15166485 |
| 70 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14426022 |
| 71 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12629912 |
| 72 | regulation of B cell differentiation (GO:0045577) | 3.12016970 |
| 73 | amino acid import (GO:0043090) | 3.11510408 |
| 74 | nerve growth factor signaling pathway (GO:0038180) | 3.11024538 |
| 75 | defense response to protozoan (GO:0042832) | 3.10390847 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08166732 |
| 77 | photoreceptor cell differentiation (GO:0046530) | 3.07522421 |
| 78 | eye photoreceptor cell differentiation (GO:0001754) | 3.07522421 |
| 79 | transmission of nerve impulse (GO:0019226) | 3.04591308 |
| 80 | microglial cell activation (GO:0001774) | 3.01412886 |
| 81 | negative regulation of adaptive immune response (GO:0002820) | 3.00756273 |
| 82 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.98850104 |
| 83 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.96940451 |
| 84 | glycerophospholipid catabolic process (GO:0046475) | 2.95902961 |
| 85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.93692043 |
| 86 | apical protein localization (GO:0045176) | 2.92701930 |
| 87 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.92434764 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.89672884 |
| 89 | response to protozoan (GO:0001562) | 2.89525144 |
| 90 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.88773388 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.88763938 |
| 92 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.88356012 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 2.87282553 |
| 94 | tolerance induction (GO:0002507) | 2.87199951 |
| 95 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.86601785 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84921555 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84921555 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 2.84075473 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83663701 |
| 100 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.83426853 |
| 101 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.83394641 |
| 102 | protein localization to endosome (GO:0036010) | 2.82615198 |
| 103 | regulation of chronic inflammatory response (GO:0002676) | 2.82472785 |
| 104 | response to muramyl dipeptide (GO:0032495) | 2.82451115 |
| 105 | T cell differentiation involved in immune response (GO:0002292) | 2.82429168 |
| 106 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.82429168 |
| 107 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.82429168 |
| 108 | negative regulation of protein localization to cell surface (GO:2000009) | 2.81784022 |
| 109 | membrane assembly (GO:0071709) | 2.80843026 |
| 110 | adult walking behavior (GO:0007628) | 2.80780897 |
| 111 | regulation of B cell proliferation (GO:0030888) | 2.80762278 |
| 112 | mast cell activation (GO:0045576) | 2.80113833 |
| 113 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79062662 |
| 114 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.78929820 |
| 115 | regulation of regulatory T cell differentiation (GO:0045589) | 2.78324381 |
| 116 | germinal center formation (GO:0002467) | 2.77191494 |
| 117 | alpha-beta T cell differentiation (GO:0046632) | 2.77184281 |
| 118 | glutamate receptor signaling pathway (GO:0007215) | 2.76784730 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.76156950 |
| 120 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75966420 |
| 121 | response to peptidoglycan (GO:0032494) | 2.75689418 |
| 122 | glutamate secretion (GO:0014047) | 2.74847268 |
| 123 | regulation of activation of Janus kinase activity (GO:0010533) | 2.73979888 |
| 124 | regulation of collateral sprouting (GO:0048670) | 2.73699324 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.72946589 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.72839778 |
| 127 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72793773 |
| 128 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.72622973 |
| 129 | positive regulation of B cell mediated immunity (GO:0002714) | 2.72622973 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 2.72575189 |
| 131 | positive regulation of B cell proliferation (GO:0030890) | 2.72087653 |
| 132 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.71276091 |
| 133 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.71276091 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.70339233 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69670888 |
| 136 | creatine metabolic process (GO:0006600) | 2.68739751 |
| 137 | activated T cell proliferation (GO:0050798) | 2.68489230 |
| 138 | hepatocyte apoptotic process (GO:0097284) | 2.68349820 |
| 139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.68041717 |
| 140 | positive regulation of interleukin-2 production (GO:0032743) | 2.66641360 |
| 141 | astrocyte development (GO:0014002) | 2.65051983 |
| 142 | positive regulation of interleukin-17 production (GO:0032740) | 2.63291237 |
| 143 | gamma-aminobutyric acid transport (GO:0015812) | 2.59542834 |
| 144 | Golgi to endosome transport (GO:0006895) | 2.58407057 |
| 145 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.58230235 |
| 146 | negative regulation of axonogenesis (GO:0050771) | 2.56178564 |
| 147 | Rap protein signal transduction (GO:0032486) | 2.54566734 |
| 148 | magnesium ion transport (GO:0015693) | 2.54151280 |
| 149 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.53739062 |
| 150 | substantia nigra development (GO:0021762) | 2.53215507 |
| 151 | myelination in peripheral nervous system (GO:0022011) | 2.52492142 |
| 152 | peripheral nervous system axon ensheathment (GO:0032292) | 2.52492142 |
| 153 | synaptic vesicle exocytosis (GO:0016079) | 2.51364717 |
| 154 | cellular potassium ion homeostasis (GO:0030007) | 2.51327460 |
| 155 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.50455107 |
| 156 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.50254378 |
| 157 | L-serine transport (GO:0015825) | 2.49490278 |
| 158 | cholesterol biosynthetic process (GO:0006695) | 2.48366594 |
| 159 | serine transport (GO:0032329) | 2.47873431 |
| 160 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.45838058 |
| 161 | regulation of dendritic spine development (GO:0060998) | 2.45800125 |
| 162 | import into cell (GO:0098657) | 2.45337420 |
| 163 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.45138834 |
| 164 | neuron-neuron synaptic transmission (GO:0007270) | 2.44389527 |
| 165 | synaptic vesicle maturation (GO:0016188) | 2.44319246 |
| 166 | cellular response to epinephrine stimulus (GO:0071872) | 2.42738648 |
| 167 | membrane tubulation (GO:0097320) | 2.41624652 |
| 168 | synaptic transmission, glutamatergic (GO:0035249) | 2.40950884 |
| 169 | negative regulation of inclusion body assembly (GO:0090084) | 2.40032062 |
| 170 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.38914394 |
| 171 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.38860193 |
| 172 | locomotory exploration behavior (GO:0035641) | 2.38277582 |
| 173 | dendritic spine morphogenesis (GO:0060997) | 2.36772673 |
| 174 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.34106040 |
| 175 | neuronal ion channel clustering (GO:0045161) | 2.33664317 |
| 176 | cyclic nucleotide catabolic process (GO:0009214) | 2.33374097 |
| 177 | negative T cell selection (GO:0043383) | 2.33331633 |
| 178 | peripheral nervous system development (GO:0007422) | 2.32368913 |
| 179 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.31931516 |
| 180 | positive regulation of action potential (GO:0045760) | 2.30616752 |
| 181 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.29683156 |
| 182 | regulation of T-helper cell differentiation (GO:0045622) | 2.29374419 |
| 183 | response to lipoprotein particle (GO:0055094) | 2.29047073 |
| 184 | positive regulation of interleukin-4 production (GO:0032753) | 2.28168292 |
| 185 | negative regulation of synaptic transmission (GO:0050805) | 2.28165536 |
| 186 | long-term synaptic potentiation (GO:0060291) | 2.28010430 |
| 187 | response to epinephrine (GO:0071871) | 2.25855316 |
| 188 | establishment of mitochondrion localization (GO:0051654) | 2.25668435 |
| 189 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.25519438 |
| 190 | protein localization to synapse (GO:0035418) | 2.25012516 |
| 191 | negative thymic T cell selection (GO:0045060) | 2.24734392 |
| 192 | glycosphingolipid biosynthetic process (GO:0006688) | 2.24387050 |
| 193 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.24331962 |
| 194 | organ growth (GO:0035265) | 2.21818028 |
| 195 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.21122041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.35477753 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.78361005 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.72292570 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22699993 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06470233 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.95209870 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.69228015 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60331186 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58898565 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.46642693 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43260375 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40999258 |
| 13 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.40335642 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.35532656 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29341491 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.28314868 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25707187 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.23060339 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17376063 |
| 20 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13514419 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.11844811 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10903751 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.08152559 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07762979 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06961381 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05435325 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.97760883 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89428800 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84381405 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82060448 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81169254 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80943448 |
| 33 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80794331 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80639887 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.79625181 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79290294 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79290294 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78939838 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77229973 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75813771 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72654949 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71390733 |
| 43 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66701337 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66559345 |
| 45 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65524949 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63697271 |
| 47 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60535299 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60404402 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58826304 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56297453 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53853585 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52815997 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52812138 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52800615 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51909588 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51053962 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50678841 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.49482994 |
| 59 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48909702 |
| 60 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47971004 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46657540 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46002153 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45362090 |
| 64 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45009737 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41860755 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39991006 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39982746 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39843888 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39432560 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38726102 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38696081 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35897417 |
| 73 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34852902 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33743978 |
| 75 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32436257 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30423546 |
| 77 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30118550 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29281735 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28721753 |
| 80 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28134499 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27834805 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27632855 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.27021875 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26162148 |
| 85 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.25700790 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24668170 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23607891 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23239814 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23079775 |
| 90 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22014222 |
| 91 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21476805 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21145578 |
| 93 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16887893 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16866165 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16066891 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15414281 |
| 97 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15008496 |
| 98 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14629301 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12878977 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12466271 |
| 101 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12465642 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12112440 |
| 103 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11384367 |
| 104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10756818 |
| 105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08510392 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07836162 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07644915 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07096337 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06302204 |
| 110 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.06088840 |
| 111 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06025727 |
| 112 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05871031 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05589888 |
| 114 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05479466 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05245717 |
| 116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05235163 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04405309 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04186590 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03944691 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03667358 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03566680 |
| 122 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03438367 |
| 123 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03293513 |
| 124 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03293513 |
| 125 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02700674 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01739139 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01207577 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00999722 |
| 129 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00984544 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00620311 |
| 131 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00497230 |
| 132 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99607917 |
| 133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99570665 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98809302 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98691707 |
| 136 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98278720 |
| 137 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97943776 |
| 138 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97716703 |
| 139 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97475352 |
| 140 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97183091 |
| 141 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97183091 |
| 142 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96970198 |
| 143 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96667851 |
| 144 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96585037 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96021081 |
| 146 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95907711 |
| 147 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95039908 |
| 148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93929965 |
| 149 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93193405 |
| 150 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92395764 |
| 151 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92278291 |
| 152 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92241210 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90851256 |
| 154 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88719991 |
| 155 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88133047 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87584503 |
| 157 | * MAF_26560356_Chip-Seq_TH2_Human | 0.86732630 |
| 158 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85355030 |
| 159 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83738414 |
| 160 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83676432 |
| 161 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82056720 |
| 162 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81448551 |
| 163 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77860078 |
| 164 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77014209 |
| 165 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74932252 |
| 166 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74118198 |
| 167 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.73684584 |
| 168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71748205 |
| 169 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71540034 |
| 170 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70854907 |
| 171 | MYC_22102868_ChIP-Seq_BL_Human | 0.68936730 |
| 172 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67262356 |
| 173 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67262356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.52543484 |
| 2 | MP0000920_abnormal_myelination | 4.03652170 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.91276645 |
| 4 | MP0004270_analgesia | 3.81430871 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.74011477 |
| 6 | MP0003303_peritoneal_inflammation | 3.35258075 |
| 7 | MP0003436_decreased_susceptibility_to | 3.12589304 |
| 8 | MP0003690_abnormal_glial_cell | 2.97284614 |
| 9 | MP0003724_increased_susceptibility_to | 2.94887395 |
| 10 | MP0001486_abnormal_startle_reflex | 2.75982972 |
| 11 | MP0009785_altered_susceptibility_to | 2.61325285 |
| 12 | MP0009046_muscle_twitch | 2.60852230 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.59551731 |
| 14 | MP0003329_amyloid_beta_deposits | 2.58044389 |
| 15 | MP0002064_seizures | 2.56791588 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.55765182 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.55408668 |
| 18 | MP0004885_abnormal_endolymph | 2.46103445 |
| 19 | MP0005025_abnormal_response_to | 2.42676995 |
| 20 | MP0004742_abnormal_vestibular_system | 2.41664319 |
| 21 | MP0009745_abnormal_behavioral_response | 2.40505253 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.38916707 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.38509700 |
| 24 | MP0002272_abnormal_nervous_system | 2.38033866 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.32802646 |
| 26 | MP0002419_abnormal_innate_immunity | 2.30852857 |
| 27 | MP0001819_abnormal_immune_cell | 2.28760198 |
| 28 | MP0010678_abnormal_skin_adnexa | 2.20652881 |
| 29 | MP0004381_abnormal_hair_follicle | 2.15243353 |
| 30 | MP0005423_abnormal_somatic_nervous | 2.07833999 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.99467713 |
| 32 | MP0005171_absent_coat_pigmentation | 1.99380880 |
| 33 | MP0000383_abnormal_hair_follicle | 1.97078240 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.93395117 |
| 35 | MP0002063_abnormal_learning/memory/cond | 1.92874112 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.91134850 |
| 37 | MP0005451_abnormal_body_composition | 1.89427661 |
| 38 | MP0000778_abnormal_nervous_system | 1.88950248 |
| 39 | MP0002398_abnormal_bone_marrow | 1.86852439 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.86342080 |
| 41 | MP0002405_respiratory_system_inflammati | 1.84598649 |
| 42 | MP0001440_abnormal_grooming_behavior | 1.83680940 |
| 43 | MP0003136_yellow_coat_color | 1.83510765 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.81901808 |
| 45 | MP0000716_abnormal_immune_system | 1.81183379 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.75459173 |
| 47 | MP0001905_abnormal_dopamine_level | 1.68926143 |
| 48 | MP0000604_amyloidosis | 1.67776376 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.67133624 |
| 50 | MP0005310_abnormal_salivary_gland | 1.66989877 |
| 51 | MP0003634_abnormal_glial_cell | 1.66815017 |
| 52 | MP0005409_darkened_coat_color | 1.64994136 |
| 53 | MP0003632_abnormal_nervous_system | 1.63450406 |
| 54 | MP0008569_lethality_at_weaning | 1.62509597 |
| 55 | MP0003866_abnormal_defecation | 1.59970270 |
| 56 | MP0001873_stomach_inflammation | 1.59587398 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.58604468 |
| 58 | MP0004142_abnormal_muscle_tone | 1.56227233 |
| 59 | MP0008057_abnormal_DNA_replication | 1.56181845 |
| 60 | MP0001501_abnormal_sleep_pattern | 1.53116335 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.48699297 |
| 62 | MP0002006_tumorigenesis | 1.47870573 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.47214559 |
| 64 | MP0003631_nervous_system_phenotype | 1.46035268 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.45174934 |
| 66 | MP0002722_abnormal_immune_system | 1.42436648 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.39812538 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.39407582 |
| 69 | MP0003633_abnormal_nervous_system | 1.38736024 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.37672508 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.37430580 |
| 72 | MP0001853_heart_inflammation | 1.36158939 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.34331784 |
| 74 | MP0005671_abnormal_response_to | 1.34053787 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.34022620 |
| 76 | MP0001529_abnormal_vocalization | 1.32583122 |
| 77 | MP0002429_abnormal_blood_cell | 1.31334097 |
| 78 | MP0005387_immune_system_phenotype | 1.29120107 |
| 79 | MP0001790_abnormal_immune_system | 1.29120107 |
| 80 | MP0001851_eye_inflammation | 1.28594373 |
| 81 | MP0002254_reproductive_system_inflammat | 1.28499106 |
| 82 | MP0005464_abnormal_platelet_physiology | 1.26690969 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.26393437 |
| 84 | MP0004924_abnormal_behavior | 1.26393437 |
| 85 | MP0009764_decreased_sensitivity_to | 1.26144988 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 1.25389883 |
| 87 | MP0002229_neurodegeneration | 1.25205325 |
| 88 | MP0003172_abnormal_lysosome_physiology | 1.24083720 |
| 89 | MP0000579_abnormal_nail_morphology | 1.21563626 |
| 90 | MP0005166_decreased_susceptibility_to | 1.17727322 |
| 91 | MP0001968_abnormal_touch/_nociception | 1.14675809 |
| 92 | MP0002796_impaired_skin_barrier | 1.13279005 |
| 93 | MP0008260_abnormal_autophagy | 1.13189849 |
| 94 | MP0002998_abnormal_bone_remodeling | 1.10266844 |
| 95 | MP0002882_abnormal_neuron_morphology | 1.09791910 |
| 96 | MP0000015_abnormal_ear_pigmentation | 1.09779310 |
| 97 | MP0003787_abnormal_imprinting | 1.09595298 |
| 98 | MP0000566_synostosis | 1.09400395 |
| 99 | MP0002009_preneoplasia | 1.09275659 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 1.09266588 |
| 101 | MP0008469_abnormal_protein_level | 1.07669836 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 1.07481412 |
| 103 | MP0000955_abnormal_spinal_cord | 1.07421509 |
| 104 | MP0005623_abnormal_meninges_morphology | 1.06962918 |
| 105 | MP0009278_abnormal_bone_marrow | 1.05002179 |
| 106 | MP0000647_abnormal_sebaceous_gland | 1.04975899 |
| 107 | MP0001545_abnormal_hematopoietic_system | 1.03977193 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 1.03977193 |
| 109 | MP0001502_abnormal_circadian_rhythm | 1.03551739 |
| 110 | MP0001970_abnormal_pain_threshold | 1.02651905 |
| 111 | MP0004883_abnormal_blood_vessel | 1.02032235 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.99975428 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.99522820 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.98673646 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.97449029 |
| 116 | MP0005000_abnormal_immune_tolerance | 0.95266266 |
| 117 | MP0004510_myositis | 0.95253050 |
| 118 | MP0005410_abnormal_fertilization | 0.94259828 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.92604915 |
| 120 | MP0003091_abnormal_cell_migration | 0.91729812 |
| 121 | MP0009780_abnormal_chondrocyte_physiolo | 0.89599010 |
| 122 | MP0000685_abnormal_immune_system | 0.89356663 |
| 123 | MP0000427_abnormal_hair_cycle | 0.89167549 |
| 124 | MP0003828_pulmonary_edema | 0.88898558 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.88340039 |
| 126 | MP0003448_altered_tumor_morphology | 0.87139360 |
| 127 | MP0008874_decreased_physiological_sensi | 0.85805651 |
| 128 | MP0006082_CNS_inflammation | 0.85049255 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.84096557 |
| 130 | MP0002736_abnormal_nociception_after | 0.83813542 |
| 131 | MP0001661_extended_life_span | 0.83207910 |
| 132 | MP0000858_altered_metastatic_potential | 0.80958226 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.80324779 |
| 134 | MP0008004_abnormal_stomach_pH | 0.80237436 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.79182974 |
| 136 | MP0001984_abnormal_olfaction | 0.77786403 |
| 137 | MP0005164_abnormal_response_to | 0.76332849 |
| 138 | MP0001800_abnormal_humoral_immune | 0.75906953 |
| 139 | MP0004147_increased_porphyrin_level | 0.75805874 |
| 140 | MP0005174_abnormal_tail_pigmentation | 0.75438207 |
| 141 | MP0004947_skin_inflammation | 0.73941210 |
| 142 | MP0003763_abnormal_thymus_physiology | 0.72593228 |
| 143 | MP0009763_increased_sensitivity_to | 0.72289787 |
| 144 | MP0001177_atelectasis | 0.72137135 |
| 145 | MP0002822_catalepsy | 0.71875644 |
| 146 | MP0004484_altered_response_of | 0.71744619 |
| 147 | MP0002723_abnormal_immune_serum | 0.71528120 |
| 148 | MP0003075_altered_response_to | 0.71372919 |
| 149 | MP0005167_abnormal_blood-brain_barrier | 0.70402714 |
| 150 | MP0000462_abnormal_digestive_system | 0.67958794 |
| 151 | MP0002152_abnormal_brain_morphology | 0.67894069 |
| 152 | MP0003300_gastrointestinal_ulcer | 0.67720291 |
| 153 | MP0009765_abnormal_xenobiotic_induced | 0.67011859 |
| 154 | MP0002735_abnormal_chemical_nociception | 0.66925688 |
| 155 | MP0001299_abnormal_eye_distance/ | 0.66456076 |
| 156 | MP0000377_abnormal_hair_follicle | 0.65434718 |
| 157 | MP0004043_abnormal_pH_regulation | 0.63465553 |
| 158 | MP0005075_abnormal_melanosome_morpholog | 0.63376832 |
| 159 | MP0002752_abnormal_somatic_nervous | 0.62480932 |
| 160 | MP0003045_fibrosis | 0.61815122 |
| 161 | MP0005646_abnormal_pituitary_gland | 0.61014051 |
| 162 | MP0000249_abnormal_blood_vessel | 0.60674026 |
| 163 | MP0002933_joint_inflammation | 0.60595931 |
| 164 | MP0001216_abnormal_epidermal_layer | 0.59917016 |
| 165 | MP0001663_abnormal_digestive_system | 0.59853364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.44630002 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.44630002 |
| 3 | Parakeratosis (HP:0001036) | 5.33212423 |
| 4 | Neurofibrillary tangles (HP:0002185) | 5.28922654 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.81501157 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 4.60940493 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.47276369 |
| 8 | Focal motor seizures (HP:0011153) | 4.33913258 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.29749584 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 3.99728622 |
| 11 | Orchitis (HP:0100796) | 3.91599050 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.91279223 |
| 13 | Myositis (HP:0100614) | 3.85639081 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.82488773 |
| 15 | Peripheral hypomyelination (HP:0007182) | 3.81869208 |
| 16 | Atonic seizures (HP:0010819) | 3.62558185 |
| 17 | Dysmetria (HP:0001310) | 3.62336638 |
| 18 | Recurrent viral infections (HP:0004429) | 3.61894044 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61571899 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.58985152 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.53140594 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.51311794 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.51311794 |
| 24 | Abnormality of T cells (HP:0002843) | 3.50600052 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.47994522 |
| 26 | Recurrent skin infections (HP:0001581) | 3.46215989 |
| 27 | Scanning speech (HP:0002168) | 3.44577011 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.36044845 |
| 29 | Spastic gait (HP:0002064) | 3.32406504 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30286303 |
| 31 | Myokymia (HP:0002411) | 3.28925587 |
| 32 | Intention tremor (HP:0002080) | 3.28380717 |
| 33 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.27307968 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.24840102 |
| 35 | Meningitis (HP:0001287) | 3.22865256 |
| 36 | Onion bulb formation (HP:0003383) | 3.18090470 |
| 37 | Thickened helices (HP:0000391) | 3.16561752 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.15997770 |
| 39 | Vasculitis (HP:0002633) | 3.07648624 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 3.03365605 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.99944400 |
| 42 | Encephalitis (HP:0002383) | 2.99671074 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.99163231 |
| 44 | Recurrent bronchitis (HP:0002837) | 2.97592241 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.96530388 |
| 46 | Slow saccadic eye movements (HP:0000514) | 2.93851668 |
| 47 | Increased IgE level (HP:0003212) | 2.92920626 |
| 48 | Pustule (HP:0200039) | 2.92078414 |
| 49 | Diplopia (HP:0000651) | 2.86992361 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.86992361 |
| 51 | Insidious onset (HP:0003587) | 2.86012433 |
| 52 | Termporal pattern (HP:0011008) | 2.86012433 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.81197210 |
| 54 | Colitis (HP:0002583) | 2.80890290 |
| 55 | Aplasia involving bones of the extremities (HP:0009825) | 2.73601913 |
| 56 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.73601913 |
| 57 | Aplasia of the phalanges of the hand (HP:0009802) | 2.73601913 |
| 58 | Megalencephaly (HP:0001355) | 2.73091988 |
| 59 | Focal seizures (HP:0007359) | 2.72643457 |
| 60 | Clumsiness (HP:0002312) | 2.72309984 |
| 61 | Hemoptysis (HP:0002105) | 2.72257647 |
| 62 | Chronic diarrhea (HP:0002028) | 2.72192092 |
| 63 | Eosinophilia (HP:0001880) | 2.71921045 |
| 64 | Gaze-evoked nystagmus (HP:0000640) | 2.71464938 |
| 65 | Progressive cerebellar ataxia (HP:0002073) | 2.69211585 |
| 66 | Hyperventilation (HP:0002883) | 2.67424305 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.64780649 |
| 68 | Leukocytosis (HP:0001974) | 2.61470322 |
| 69 | Akinesia (HP:0002304) | 2.60788074 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.57443940 |
| 71 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.57262348 |
| 72 | Cerebral hemorrhage (HP:0001342) | 2.56770919 |
| 73 | Broad-based gait (HP:0002136) | 2.53656415 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.53644286 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53464998 |
| 76 | Increased IgM level (HP:0003496) | 2.53292778 |
| 77 | Gingivitis (HP:0000230) | 2.53282700 |
| 78 | Alacrima (HP:0000522) | 2.50680754 |
| 79 | IgG deficiency (HP:0004315) | 2.50631697 |
| 80 | Abnormality of eosinophils (HP:0001879) | 2.49908491 |
| 81 | Granulocytopenia (HP:0001913) | 2.44755378 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.44466528 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.43645152 |
| 84 | Abnormal auditory evoked potentials (HP:0006958) | 2.43099108 |
| 85 | Pulmonary embolism (HP:0002204) | 2.41210856 |
| 86 | Severe combined immunodeficiency (HP:0004430) | 2.37769775 |
| 87 | Arterial thrombosis (HP:0004420) | 2.36782185 |
| 88 | Metabolic alkalosis (HP:0200114) | 2.35380761 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.34477404 |
| 90 | Papilledema (HP:0001085) | 2.33783756 |
| 91 | Premature skin wrinkling (HP:0100678) | 2.31923421 |
| 92 | Thyroiditis (HP:0100646) | 2.31605157 |
| 93 | Increased circulating renin level (HP:0000848) | 2.31588239 |
| 94 | Cupped ear (HP:0000378) | 2.30508626 |
| 95 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.30439538 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 2.27777422 |
| 97 | Viral hepatitis (HP:0006562) | 2.26998151 |
| 98 | Chest pain (HP:0100749) | 2.26741570 |
| 99 | Action tremor (HP:0002345) | 2.26570957 |
| 100 | Dysdiadochokinesis (HP:0002075) | 2.26231296 |
| 101 | Abnormality of T cell physiology (HP:0011840) | 2.26186484 |
| 102 | Chronic otitis media (HP:0000389) | 2.25343931 |
| 103 | IgA deficiency (HP:0002720) | 2.22896114 |
| 104 | Erythroderma (HP:0001019) | 2.20680386 |
| 105 | Widely spaced teeth (HP:0000687) | 2.20210849 |
| 106 | B lymphocytopenia (HP:0010976) | 2.19951098 |
| 107 | Subacute progressive viral hepatitis (HP:0006572) | 2.19597408 |
| 108 | Joint swelling (HP:0001386) | 2.19399045 |
| 109 | Urticaria (HP:0001025) | 2.19079854 |
| 110 | Abnormality of T cell number (HP:0011839) | 2.17147278 |
| 111 | T lymphocytopenia (HP:0005403) | 2.16949444 |
| 112 | Ankle clonus (HP:0011448) | 2.16512525 |
| 113 | Dialeptic seizures (HP:0011146) | 2.14395689 |
| 114 | Decreased lacrimation (HP:0000633) | 2.13395999 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 2.11358898 |
| 116 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.11067288 |
| 117 | Optic neuritis (HP:0100653) | 2.09568400 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 2.09568400 |
| 119 | Lower limb muscle weakness (HP:0007340) | 2.08254443 |
| 120 | Cellulitis (HP:0100658) | 2.07572842 |
| 121 | Thick nail (HP:0001805) | 2.07209780 |
| 122 | Absence seizures (HP:0002121) | 2.06738764 |
| 123 | Partial agenesis of the corpus callosum (HP:0001338) | 2.06722424 |
| 124 | Excessive salivation (HP:0003781) | 2.05230473 |
| 125 | Drooling (HP:0002307) | 2.05230473 |
| 126 | Verrucae (HP:0200043) | 2.03374600 |
| 127 | Papilloma (HP:0012740) | 2.03374600 |
| 128 | Blue irides (HP:0000635) | 2.03020308 |
| 129 | Anteriorly placed anus (HP:0001545) | 2.01916878 |
| 130 | Gingival bleeding (HP:0000225) | 2.01582541 |
| 131 | Progressive inability to walk (HP:0002505) | 2.00873488 |
| 132 | Urinary urgency (HP:0000012) | 2.00399539 |
| 133 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99724482 |
| 134 | Obstructive lung disease (HP:0006536) | 1.99724482 |
| 135 | Abnormality of the fingertips (HP:0001211) | 1.96793378 |
| 136 | Split foot (HP:0001839) | 1.95703638 |
| 137 | Generalized myoclonic seizures (HP:0002123) | 1.95532175 |
| 138 | Stomatitis (HP:0010280) | 1.94825594 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.93428282 |
| 140 | Alveolar cell carcinoma (HP:0006519) | 1.92296178 |
| 141 | Febrile seizures (HP:0002373) | 1.91893689 |
| 142 | Osteomyelitis (HP:0002754) | 1.91402534 |
| 143 | Abnormality of salivation (HP:0100755) | 1.91250927 |
| 144 | Fair hair (HP:0002286) | 1.90532248 |
| 145 | Autoamputation (HP:0001218) | 1.89373218 |
| 146 | Absent septum pellucidum (HP:0001331) | 1.88160942 |
| 147 | Vertigo (HP:0002321) | 1.87051373 |
| 148 | Gangrene (HP:0100758) | 1.87013503 |
| 149 | Hemiparesis (HP:0001269) | 1.86849193 |
| 150 | Abnormality of saccadic eye movements (HP:0000570) | 1.86075642 |
| 151 | Combined immunodeficiency (HP:0005387) | 1.85479903 |
| 152 | Interstitial pulmonary disease (HP:0006530) | 1.85226176 |
| 153 | Stomach cancer (HP:0012126) | 1.84696202 |
| 154 | Abnormality of the pleura (HP:0002103) | 1.84657333 |
| 155 | Anorexia (HP:0002039) | 1.84306605 |
| 156 | Lymphopenia (HP:0001888) | 1.84175521 |
| 157 | Oligodactyly (hands) (HP:0001180) | 1.83752959 |
| 158 | Abnormal hair whorl (HP:0010721) | 1.82390973 |
| 159 | Hypokalemic alkalosis (HP:0001949) | 1.82246362 |
| 160 | Ectropion (HP:0000656) | 1.82165394 |
| 161 | Hypoplasia of the iris (HP:0007676) | 1.81970583 |
| 162 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81134815 |
| 163 | Sepsis (HP:0100806) | 1.80912325 |
| 164 | Chin dimple (HP:0010751) | 1.80753411 |
| 165 | Increased CSF protein (HP:0002922) | 1.80218999 |
| 166 | Long nose (HP:0003189) | 1.77839375 |
| 167 | Hemiplegia (HP:0002301) | 1.75843294 |
| 168 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.74375916 |
| 169 | Truncal ataxia (HP:0002078) | 1.74247786 |
| 170 | Relative macrocephaly (HP:0004482) | 1.72975004 |
| 171 | Spastic tetraparesis (HP:0001285) | 1.72564333 |
| 172 | Generalized tonic-clonic seizures (HP:0002069) | 1.72553433 |
| 173 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.72403055 |
| 174 | Conical tooth (HP:0000698) | 1.72353661 |
| 175 | Esophageal atresia (HP:0002032) | 1.71391264 |
| 176 | Postural instability (HP:0002172) | 1.71083324 |
| 177 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.70919973 |
| 178 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70655335 |
| 179 | Absent/shortened dynein arms (HP:0200106) | 1.70655335 |
| 180 | Absent speech (HP:0001344) | 1.70095415 |
| 181 | Confusion (HP:0001289) | 1.69782273 |
| 182 | Aqueductal stenosis (HP:0002410) | 1.69100103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.70804475 |
| 2 | OXSR1 | 4.20054318 |
| 3 | EPHA4 | 3.07003646 |
| 4 | CDK19 | 2.92937047 |
| 5 | EPHB1 | 2.71895945 |
| 6 | TNIK | 2.59798745 |
| 7 | TAOK3 | 2.50190992 |
| 8 | FGFR2 | 2.40554750 |
| 9 | TYK2 | 2.39062007 |
| 10 | CASK | 2.30348108 |
| 11 | MAP3K13 | 2.25721287 |
| 12 | BCR | 2.18791631 |
| 13 | MST4 | 2.08516556 |
| 14 | PKN1 | 1.90673455 |
| 15 | PAK6 | 1.82954330 |
| 16 | SYK | 1.75337483 |
| 17 | IRAK4 | 1.73725175 |
| 18 | BTK | 1.72246700 |
| 19 | ZAP70 | 1.69873126 |
| 20 | WNK1 | 1.66518866 |
| 21 | RIPK4 | 1.59163244 |
| 22 | FGFR3 | 1.59071727 |
| 23 | CAMKK2 | 1.56891477 |
| 24 | NEK6 | 1.49024599 |
| 25 | WNK4 | 1.47754433 |
| 26 | TYRO3 | 1.46437120 |
| 27 | FGR | 1.40889334 |
| 28 | MAP3K14 | 1.39728031 |
| 29 | MET | 1.37797725 |
| 30 | MAP3K9 | 1.36885682 |
| 31 | BMPR2 | 1.34749409 |
| 32 | SGK2 | 1.34630799 |
| 33 | PRKCQ | 1.33145931 |
| 34 | NLK | 1.31638989 |
| 35 | PIK3CG | 1.31081141 |
| 36 | JAK2 | 1.29670439 |
| 37 | HCK | 1.28794165 |
| 38 | TXK | 1.28350832 |
| 39 | TEC | 1.26499936 |
| 40 | CSNK1A1L | 1.26142421 |
| 41 | CAMK2B | 1.22780302 |
| 42 | ROCK2 | 1.20453663 |
| 43 | TBK1 | 1.20003349 |
| 44 | NTRK1 | 1.18606247 |
| 45 | ITK | 1.17369525 |
| 46 | PRPF4B | 1.16542806 |
| 47 | MAP3K3 | 1.15040426 |
| 48 | GRK6 | 1.14304553 |
| 49 | CAMKK1 | 1.13477276 |
| 50 | CSNK1G2 | 1.12603523 |
| 51 | MAP2K3 | 1.12430962 |
| 52 | MAP3K1 | 1.09981222 |
| 53 | CSNK1G3 | 1.09191900 |
| 54 | RIPK1 | 1.09132564 |
| 55 | SGK3 | 1.09126953 |
| 56 | NTRK2 | 1.07811826 |
| 57 | MARK3 | 1.07368031 |
| 58 | LYN | 1.06211467 |
| 59 | CLK1 | 1.05580683 |
| 60 | MAP3K4 | 1.05111746 |
| 61 | DMPK | 1.04315584 |
| 62 | SGK494 | 1.03995119 |
| 63 | SGK223 | 1.03995119 |
| 64 | PAK3 | 1.02064816 |
| 65 | CDK5 | 1.00000780 |
| 66 | NTRK3 | 0.99682314 |
| 67 | MAPKAPK5 | 0.98072162 |
| 68 | FGFR4 | 0.97651818 |
| 69 | PNCK | 0.95711071 |
| 70 | CSNK1G1 | 0.94693177 |
| 71 | PBK | 0.94659111 |
| 72 | CSF1R | 0.94524241 |
| 73 | ERBB4 | 0.94372515 |
| 74 | STK24 | 0.93490851 |
| 75 | KSR2 | 0.93108723 |
| 76 | STK11 | 0.91776674 |
| 77 | SIK3 | 0.88948811 |
| 78 | MAP3K12 | 0.88893247 |
| 79 | IRAK1 | 0.88550875 |
| 80 | KIT | 0.88057267 |
| 81 | CAMK2A | 0.85529319 |
| 82 | MARK2 | 0.84148799 |
| 83 | PIM1 | 0.81786932 |
| 84 | MAP2K7 | 0.81311271 |
| 85 | PDPK1 | 0.79624778 |
| 86 | CAMK2D | 0.79603665 |
| 87 | GRK7 | 0.76720016 |
| 88 | FRK | 0.75770942 |
| 89 | TNK2 | 0.75191244 |
| 90 | FES | 0.74726570 |
| 91 | SCYL2 | 0.74216815 |
| 92 | CAMK2G | 0.73266049 |
| 93 | CHUK | 0.72718561 |
| 94 | HIPK2 | 0.71931982 |
| 95 | MAPK12 | 0.71463721 |
| 96 | PTK2B | 0.70930408 |
| 97 | RAF1 | 0.70908900 |
| 98 | DAPK2 | 0.70011952 |
| 99 | FYN | 0.68933021 |
| 100 | BRD4 | 0.68576935 |
| 101 | TGFBR2 | 0.68466793 |
| 102 | PDK1 | 0.67857141 |
| 103 | PRKCH | 0.67056893 |
| 104 | CDK3 | 0.66752824 |
| 105 | ICK | 0.64393882 |
| 106 | JAK1 | 0.63683402 |
| 107 | PDGFRB | 0.62962387 |
| 108 | STK10 | 0.62898950 |
| 109 | MAPK7 | 0.62355353 |
| 110 | PRKCE | 0.61589163 |
| 111 | TRPM7 | 0.61200484 |
| 112 | MAP3K11 | 0.60984112 |
| 113 | UHMK1 | 0.58501323 |
| 114 | NUAK1 | 0.57735824 |
| 115 | MAP4K1 | 0.57466342 |
| 116 | CAMK4 | 0.56746218 |
| 117 | TAOK1 | 0.55813784 |
| 118 | GRK5 | 0.54872476 |
| 119 | IRAK2 | 0.54404092 |
| 120 | MAP3K7 | 0.54354619 |
| 121 | MAP3K2 | 0.54172269 |
| 122 | MAPK11 | 0.53711549 |
| 123 | SGK1 | 0.53410416 |
| 124 | ARAF | 0.52992186 |
| 125 | MAP3K5 | 0.51433871 |
| 126 | CSNK1D | 0.51145270 |
| 127 | LCK | 0.50798422 |
| 128 | CSK | 0.50570136 |
| 129 | IKBKE | 0.50102367 |
| 130 | CDK14 | 0.50002235 |
| 131 | CAMK1G | 0.49532326 |
| 132 | SIK2 | 0.49163748 |
| 133 | CDK15 | 0.47851224 |
| 134 | EGFR | 0.47270476 |
| 135 | RET | 0.47135760 |
| 136 | TAOK2 | 0.46787193 |
| 137 | YES1 | 0.45747129 |
| 138 | JAK3 | 0.45506200 |
| 139 | MELK | 0.44807261 |
| 140 | CDK18 | 0.44551311 |
| 141 | PRKD1 | 0.43163484 |
| 142 | CDK11A | 0.42700819 |
| 143 | PIK3CA | 0.42694388 |
| 144 | CDK6 | 0.42612909 |
| 145 | IKBKB | 0.42127952 |
| 146 | PRKG1 | 0.40086447 |
| 147 | MOS | 0.39966524 |
| 148 | BLK | 0.39378767 |
| 149 | MAPK13 | 0.39280132 |
| 150 | EPHA3 | 0.38698560 |
| 151 | KSR1 | 0.38083371 |
| 152 | MARK1 | 0.37723996 |
| 153 | ABL1 | 0.37507124 |
| 154 | PLK2 | 0.37474042 |
| 155 | MAP2K6 | 0.36759416 |
| 156 | DYRK1A | 0.36486219 |
| 157 | LIMK1 | 0.34491684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.27216845 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.25077807 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16940325 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02579870 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95992655 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.92726778 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 1.89881711 |
| 8 | Asthma_Homo sapiens_hsa05310 | 1.88151304 |
| 9 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.84913070 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.84295063 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.82070927 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.79522918 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75636684 |
| 14 | Axon guidance_Homo sapiens_hsa04360 | 1.75280209 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.74263527 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69669715 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69587430 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.65715798 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63815088 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61460634 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59038052 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59033770 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56117115 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.55811475 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55802802 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53762055 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.52459799 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.48054553 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47053640 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45588366 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.44295988 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44038345 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43869248 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.41566431 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.41405367 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40219461 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33889455 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30864477 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24471024 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24090354 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.23123592 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.22132662 |
| 43 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21473981 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16937767 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15445848 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14456706 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13756196 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.12617698 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12155885 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11889270 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11832281 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10059327 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10005893 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.09204843 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.07675829 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06863550 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04421856 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04274654 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03295360 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03119264 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02968340 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02387442 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02168983 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 1.02102833 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01510095 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.00974860 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.00525646 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98879320 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98497163 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.95801731 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94153230 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93140069 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91872035 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91307034 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90797374 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90562876 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.89762187 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89274559 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88146250 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.87049306 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85785463 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85391855 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84822695 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84583371 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84258862 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.82987295 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82908714 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81404011 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80473555 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79564727 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77308356 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77006605 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76113432 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76081926 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75966849 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75386545 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75321272 |
| 98 | * Endocytosis_Homo sapiens_hsa04144 | 0.73354829 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73049498 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72643465 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70214027 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70160401 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.68453301 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68167057 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65723741 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65607747 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64889720 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64737853 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.64621172 |
| 110 | Insulin secretion_Homo sapiens_hsa04911 | 0.63766965 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.62862592 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61869394 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60901268 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.60388422 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.59583057 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56760581 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.56228444 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55232809 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54521342 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54449138 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53910116 |
| 122 | Melanogenesis_Homo sapiens_hsa04916 | 0.53769728 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53727879 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52238026 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50696984 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50522401 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50459927 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49837646 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49835797 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49348222 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48891909 |
| 132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48849335 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48417376 |
| 134 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47606966 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47513558 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.46612615 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45127789 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44882470 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43489446 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.40459350 |
| 141 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40248588 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39985790 |
| 143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39244902 |
| 144 | Glioma_Homo sapiens_hsa05214 | 0.38055654 |
| 145 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37476215 |

